Episode 17: Amy Fenton Parker, President and CEO at Batten Disease Support and Research Organization (BDSRA)

Episode 17 January 12, 2022 00:39:58
Episode 17: Amy Fenton Parker, President and CEO at Batten Disease Support and Research Organization (BDSRA)
Few & Far Between: Conversations from the Front Lines of Drug Development
Episode 17: Amy Fenton Parker, President and CEO at Batten Disease Support and Research Organization (BDSRA)

Jan 12 2022 | 00:39:58

/

Show Notes

Why are advocacy and accessibility so important to rare diseases such as Batten Disease? On this week’s Few & Far Between podcast episode, Biorasi’s Becky Knockemus talks with Amy Fenton Parker, President and CEO at Batten Disease Support and Research Organization (BDSRA).

Other Episodes

Episode 12

October 13, 2021 00:46:48
Episode Cover

Episode 12: Effie Parks and Spela Mirosevic

Social media platforms and podcasts are spotlighting the untold stories of rare disease patients and their families. Find out more in today's Few &...

Listen

Episode 25

November 17, 2022 00:39:44
Episode Cover

Episode 25: Jim Geraghty, Author and Biotech Industry Veteran

“We can’t take the orphan drug revolution for granted.“ Biorasi’s Few & Far Between Podcast welcomes Jim Geraghty, author and biotech industry veteran, to...

Listen

Episode 20

May 18, 2022 00:30:43
Episode Cover

Episode 20: Professor Bertil E. Lindmark MD, PhD, Author and CMO at Galecto, Inc.

What do the next 100 years have in store for healthcare and clinical research? Biorasi's Few & Far Between podcast welcomes Professor Bertil E....

Listen